logologo
QuantliQuantli

Century Therapeutics Inc

IPSC

NASDAQ

Biotechnology

$1.92

USD

-0.01 (-0.52%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $348.08M

Volume 489.3K

Price Target

$8.00$8.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $8.00 and a min estimate of $8.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$8.00

+$3.0 vs prior

Implied Upside

+316.7%

+156.3% vs prior

Analyst Covering

1

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Salim Syed

Mizuho

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

STRO

Sutro Biopharma Inc

$20.48

-3.9%

ZNTL

Zentalis Pharmaceuticals Inc

$3.56

-14.2%

FHTX

Foghorn Therapeutics Inc

$6.26

-3.5%

GALT

Galectin Therapeutics Inc

$3.44

-2.5%

LYEL

Lyell Immunopharma Inc

$13.95

+1.5%

IKT

Inhibikase Therapeutics Inc

$2.41

0.0%

DMAC

DiaMedica Therapeutics Inc

$6.68

-1.0%

ABEO

Abeona Therapeutics Inc

$5.99

-5.7%

SABS

SAB Biotherapeutics Inc

$3.70

-1.3%